The purines: Potent and versatile small molecule inhibitors and modulators of key biological targets
Top Cited Papers
- 15 June 2006
- journal article
- review article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 14 (12), 3987-4006
- https://doi.org/10.1016/j.bmc.2005.12.060
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2Bioorganic & Medicinal Chemistry Letters, 2005
- Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2004
- Improved antiviral activity of the aryloxymethoxyalaninyl phosphoramidate (APA) prodrug of abacavir (ABC) is due to the formation of markedly increased carbovir 5′‐triphosphate metabolite levelsFEBS Letters, 2004
- Sulfotransferases: Structure, Mechanism, Biological Activity, Inhibition, and Synthetic UtilityAngewandte Chemie, 2004
- Identification of purine inhibitors of phosphodiesterase 7 (PDE7)Bioorganic & Medicinal Chemistry Letters, 2004
- SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunctionBioorganic & Medicinal Chemistry Letters, 2004
- 2,6,8,9-Tetrasubstituted Purines as New CDK1 InhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- Pyrazolo[4,3-d]pyrimidines as new generation of cyclin-dependent kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- N-Phenyl-N-purin-6-yl ureas: The design and synthesis of p38α MAP kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- Synthesis and activity of 2,6,9-trisubstituted purinesBioorganic & Medicinal Chemistry Letters, 1997